Publications by authors named "Stefanie Cantin"
Article Synopsis
- Oral cavity squamous cell carcinoma (OCSCC) is challenging to treat, often leading to toxic side effects from conventional chemotherapy like platinum-based drugs.
- PRV111 is a new nanotechnology that allows for localized delivery of cisplatin to tumors, minimizing systemic exposure and toxicity while enhancing drug retention in the tumor.
- In animal studies and a clinical trial, PRV111 showed significant effectiveness with a 69% reduction in tumor size in about a week, no serious side effects, and suggests potential for better patient outcomes when combined with existing treatments for OCSCC.
